Hepatitis C infection and the patient with end-stage renal disease | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Hepatitis C infection and the patient with end-stage renal disease

Fabrizi F, Poordad F, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36(1):3-10.

Publication Type:

Journal Article

Authors:

Fabrizi, F.; Fred Poordad; Martin, P.

Source:

Hepatology, Volume 36, Issue 1, p.3-10 (2002)

Keywords:

adverse effects, Affect, Biopsy, complications, Cross Infection, Disease, drug therapy, epidemiology, Graft Survival, HCV, hepatitis, Hepatitis C, hepatitis C virus, history, Humans, Infection, interferon, Interferons, Italy, Kidney Failure,Chronic, Kidney Transplantation, Liver, Morbidity, Mortality, Patients, PROVIDE, Renal, Renal Dialysis, Ribavirin, Survival, Survival Rate, therapeutic use, therapy, Tissue Donors, Treatment Outcome

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/12085342

Export Citation:

RIS Format

Top